Next Article in Journal / Special Issue
Onychomycosis: A Review
Previous Article in Journal / Special Issue
Cutaneous Protothecosis in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review
Article Menu

Export Article

Open AccessReview
J. Fungi 2015, 1(1), 13-29; doi:10.3390/jof1010013

Antifungal Treatment for Pityriasis Versicolor

1
Department of Medicine, University of Toronto, Toronto, ON M5G 2C4, Canada
2
Mediprobe Research Inc., London, ON N5X 2P1, Canada
*
Author to whom correspondence should be addressed.
Academic Editor: Theodore Rosen
Received: 24 December 2014 / Revised: 3 March 2015 / Accepted: 4 March 2015 / Published: 12 March 2015
(This article belongs to the Special Issue Cutaneous Fungal Diseases)
View Full-Text   |   Download PDF [528 KB, uploaded 12 March 2015]

Abstract

Background: Pityriasis versicolor (PV), also known as tinea versicolor, is caused by Malassezia species. This condition is one of the most common superficial fungal infections worldwide, particularly in tropical climates. PV is difficult to cure and the chances for relapse or recurrent infections are high due to the presence of Malassezia in the normal skin flora. This review focuses on the clinical evidence supporting the efficacy of antifungal treatment for PV. Method: A systematic review of literature from the PubMed database was conducted up to 30 September 2014. The search criteria were “(pityriasis versicolor OR tinea versicolor) AND treatment”, with full text available and English language required. Conclusions: Topical antifungal medications are the first-line treatment for PV, including zinc pyrithione, ketoconazole, and terbinafine. In cases of severe or recalcitrant PV, the oral antifungal medications itraconazole and fluconazole may be more appropriate, with pramiconazole a possible future option. Oral terbinafine is not effective in treating PV and oral ketoconazole should no longer be prescribed. Maintenance, or prophylactic, therapy may be useful in preventing recurrent infection; however, at this time, there is limited research evaluating the efficacy of prophylactic antifungal treatment. View Full-Text
Keywords: tinea versicolor; Malassezia; topical antifungals; oral antifungals; ketoconazole tinea versicolor; Malassezia; topical antifungals; oral antifungals; ketoconazole
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Gupta, A.K.; Foley, K.A. Antifungal Treatment for Pityriasis Versicolor. J. Fungi 2015, 1, 13-29.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Fungi EISSN 2309-608X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top